GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changzhou Qianhong Biopharma Co Ltd (SZSE:002550) » Definitions » Dividend Payout Ratio

Changzhou Qianhong Biopharma Co (SZSE:002550) Dividend Payout Ratio : 0.00 (As of Sep. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Changzhou Qianhong Biopharma Co Dividend Payout Ratio?

Changzhou Qianhong Biopharma Co's dividend payout ratio for the months ended in Sep. 2023 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Changzhou Qianhong Biopharma Co Ltd is 0.79, which seems too high.

The historical rank and industry rank for Changzhou Qianhong Biopharma Co's Dividend Payout Ratio or its related term are showing as below:

SZSE:002550' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.44   Med: 0.82   Max: 1.92
Current: 0.79


During the past 13 years, the highest Dividend Payout Ratio of Changzhou Qianhong Biopharma Co was 1.92. The lowest was 0.44. And the median was 0.82.

SZSE:002550's Dividend Payout Ratio is ranked worse than
86.45% of 428 companies
in the Drug Manufacturers industry
Industry Median: 0.33 vs SZSE:002550: 0.79

As of today (2024-04-28), the Dividend Yield % of Changzhou Qianhong Biopharma Co is 2.31%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Changzhou Qianhong Biopharma Co was 6.85%. The lowest was 0.38%. And the median was 1.89%.

Changzhou Qianhong Biopharma Co's Dividends per Share for the months ended in Sep. 2023 was ¥0.00.

During the past 5 years, the average Dividends Per Share Growth Rate was 12.00% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 11.60% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Changzhou Qianhong Biopharma Co was 46.20% per year. The lowest was -7.20% per year. And the median was 17.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Changzhou Qianhong Biopharma Co Dividend Payout Ratio Historical Data

The historical data trend for Changzhou Qianhong Biopharma Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changzhou Qianhong Biopharma Co Dividend Payout Ratio Chart

Changzhou Qianhong Biopharma Co Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.89 0.75 1.92 1.20 0.60

Changzhou Qianhong Biopharma Co Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 4.62 -

Competitive Comparison of Changzhou Qianhong Biopharma Co's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Changzhou Qianhong Biopharma Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Changzhou Qianhong Biopharma Co's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Changzhou Qianhong Biopharma Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Changzhou Qianhong Biopharma Co's Dividend Payout Ratio falls into.



Changzhou Qianhong Biopharma Co Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Changzhou Qianhong Biopharma Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2022 )/ EPS without NRI (A: Dec. 2022 )
=0.12/ 0.2
=0.60

Changzhou Qianhong Biopharma Co's Dividend Payout Ratio for the quarter that ended in Sep. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2023 )/ EPS without NRI (Q: Sep. 2023 )
=0/ 0.056
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Changzhou Qianhong Biopharma Co (SZSE:002550) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Changzhou Qianhong Biopharma Co Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Changzhou Qianhong Biopharma Co's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Changzhou Qianhong Biopharma Co (SZSE:002550) Business Description

Traded in Other Exchanges
N/A
Address
Number 90 Changjiang Middle Road, Xinbei distract, Jiangsu Province, Changzhou, CHN, 213022
Changzhou Qianhong Biopharma Co Ltd engages in the research and development, production, and sale of biopharmaceutical products with the focus on polysaccharides and enzymes in China. The company provides various products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; and kallidinogenase kallikrein and heparinoid.

Changzhou Qianhong Biopharma Co (SZSE:002550) Headlines

No Headlines